5A70

ICD-11 MMS 2026-01

Cushing syndrome

Description

Cushing syndrome results from excess of corticosteroid hormones in the body due to overstimulation of the adrenal glands by excessive amounts of adrenocorticotropic hormone (ACTH), secreted either by a tumuor of the pituitary gland (Cushing's disease) or by a malignant tumour in the lung or elsewhere. Symptoms include weight gain, reddening of the face and neck, excess growth of body and facial hair, raised blood pressure, loss of mineral from the bones (osteoporosis), raised blood glucose levels, and sometimes mental disturbances.

Exclusions from above levels

  • 18 – Pregnancy, childbirth or the puerperium
  • http://id.who.int/icd/entity/1004987305 – Transitory endocrine or metabolic disorders specific to fetus or newborn

Child codes

  • 5A70.0 – Pituitary-dependent Cushing disease
  • 5A70.1 – Ectopic ACTH syndrome
  • 5A70.2 – Pseudo-Cushing syndrome
  • 5A70.3 – Nelson syndrome
  • 5A70.Y – Other specified Cushing syndrome
  • 5A70.Z – Cushing syndrome, unspecified

Sibling codes

  • 5A71 – Adrenogenital disorders
  • 5A72 – Hyperaldosteronism
  • 5A73 – Hypoaldosteronism
  • 5A74 – Adrenocortical insufficiency
  • 5A75 – Adrenomedullary hyperfunction
  • 5A76 – Certain specified disorders of adrenal gland
  • 5A7Z – Disorders of the adrenal glands or adrenal hormone system, unspecified

Foundation entity

Cushing syndrome – http://id.who.int/icd/entity/1654321425

Part of: 05: Endocrine, nutritional or metabolic diseases